Updated:
Foundery Innovations
Foundery Innovations is a venture studio focused on immunotherapy in the biotechnology sector. The company develops drug discovery programs for autoimmunity,...
Foundery Innovations
Foundery Innovations is a venture studio focused on immunotherapy in the biotechnology sector. The company develops drug discovery programs for autoimmunity, inflammation, and immuno-oncology. It partners with universities to advance research and develop development candidate packages.
General information
Firm type
Private Equity
Year founded
2021
Location
Region
North America
Country
United States
City
San Francisco
Corporate office
San Francisco, CA, United States
Frequently asked questions
What investment stages does Foundery Innovations target?
The firm concentrates on early-stage and seed rounds, stepping in during company formation. It prioritizes initial venture capital injections before institutional Series A rounds.
How does Foundery Innovations source deals?
Based in San Francisco, the firm likely taps the Bay Area's dense network of accelerators, angel investors, and university programs. Public records do not detail specific sourcing channels.
Is Foundery Innovations part of a larger financial group?
There is no public evidence linking it to a parent company or multi-family office structure. Available information suggests an independent, standalone venture operation.
Does Foundery Innovations take board seats?
Its board posture is not publicly documented. Early-stage investors of this profile commonly request board observer rights or seats, but no formal policy has been disclosed.
Which sectors does Foundery Innovations avoid?
The firm's website does not list explicit exclusions. Given the early-stage focus, it likely avoids capital-intensive industrial or infrastructure plays requiring later-stage scale.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: